CN105866317B - The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase - Google Patents

The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase Download PDF

Info

Publication number
CN105866317B
CN105866317B CN201610199973.1A CN201610199973A CN105866317B CN 105866317 B CN105866317 B CN 105866317B CN 201610199973 A CN201610199973 A CN 201610199973A CN 105866317 B CN105866317 B CN 105866317B
Authority
CN
China
Prior art keywords
protein
polypeptide
classification
reverse phase
protein group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610199973.1A
Other languages
Chinese (zh)
Other versions
CN105866317A (en
Inventor
田瑞军
陈文东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Shenweichao Biotechnology Co.,Ltd.
Original Assignee
Southwest University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest University of Science and Technology filed Critical Southwest University of Science and Technology
Priority to CN201610199973.1A priority Critical patent/CN105866317B/en
Publication of CN105866317A publication Critical patent/CN105866317A/en
Priority to US16/089,503 priority patent/US11959891B2/en
Priority to PCT/CN2017/070336 priority patent/WO2017166897A1/en
Application granted granted Critical
Publication of CN105866317B publication Critical patent/CN105866317B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/89Inverse chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/067Preparation by reaction, e.g. derivatising the sample

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The protein group reactor being classified the present invention relates to integrated protein pre-treatment and polypeptide high ph-values reverse phase and its application, the protein group reactor include liquid-transfering gun pipette tips (1), strong cation-exchanging resin filler (2) and solid-phase extraction membrane (3);Solid-phase extraction membrane (3) is filled in the lower end of liquid-transfering gun pipette tips (1), and strong cation-exchanging resin filler (2) is filled in liquid-transfering gun pipette tips (1) lower end and on solid-phase extraction membrane (3).Protein group reactor provided by the invention is integrated with the operations such as preenrichment, reduction, alkylation, enzymolysis, the desalination of polypeptide, elution and the classification of high ph-values reverse phase of protein, available in the protein Large scale identification and quantitative proteomics of a small amount of cell or tissue sample;In addition, protein group reactor technology provided by the invention can realize the automation mechanized operation based on automated fluid processing platform (such as Agilent Bravo platforms etc.), sample processing throughput and quantitative analysis accuracy are improved.

Description

Integrated protein pre-treatment and the protein group reactor of polypeptide high ph-values reverse phase classification And its application
Technical field
The present invention relates to qualitative and quantitative proteomics technical field more particularly to a kind of integrated protein pre-treatment and The protein group reactor of polypeptide high ph-values reverse phase classification and its application.
Background technology
In proteomics research, by by the protein digestion in sample into after polypeptide, for liquid chromatography-mass spectrography point To obtain protein information, which is current most popular proteomics research means for analysis.
Proteomics sample pre-treatments step is mainly including the preenrichment of protein, reduction, alkylation, enzymolysis and more The desalination of peptide, classification.Conventional method is related to multiple sample transfer when handling protein sample, be easy to cause sample pollution and damage It loses.Above-mentioned steps are effectively integrated by the protein group reactor developed in recent years, substantially increase a small amount of protein sample Treatment effeciency.Rare cell protein group reactor (Rare Cell Proteomic Reactor, RCPR) based on it is strong sun from Sub-exchange resin (Strong Cation Exchange, SCX) capillary monolithic column, realize the preenrichment of protein, reduction, The classification of alkylation, enzymolysis and polypeptide, identifies 409 and 2,281 protein respectively from 5,000 and 50,000 cells (Mol.Cell.Proteomics 2011,10,M110.000679).The protein group reactor (Centrifugal of centrifugation Proteomic Reactor) pre-treatment step of protein is completed in centrifuge using centrifuge tube and SCX fillers, significantly Ground improves the identification quantity (Mol.Cell.Proteomics 2011,10, O111.008425) of memebrane protein.Narrow closing is empty Between protein example pre-treating method (in-StageTip method) sample of protein is realized in the tubule of closing Pre-treatment, and pass through the realizations such as the SCX films of tubule lower end, strong anion exchange (Strong Anion Exchange, SAX) film The classification of polypeptide identifies more than 7,000 protein (Nat.Methods 2014,11,319) from 20 μ g protein samples.
However, proteolysis and the polypeptide classification due to RCPR are all completed on SCX resins, the effect of classification is affected; Also, classification can also influence mass spectrographic detection efficiency online based on salinity.The protein group reactor of centrifugation 1.5mL from It is operated in heart pipe, operational volume is big, easily causes the loss of micro-example.In-StageTip method using SCX films into The salinity that row polypeptide uses when being classified is higher, influences Mass Spectrometer Method;Other desalination is wanted when being classified using SAX, sample is caused to damage It loses;And using C18The high ph-values reverse phase classification of polypeptide is not carried out during film.In addition, without surface-active in its lysate for using Agent is unfavorable for the dissolving and extraction of hydrophobic protein.
Therefore a kind of integrated protein pre-treatment and reverse phase classification, high-throughput and easy-operating protein how to be developed Group reactor has become current urgent problem to be solved.
Invention content
In view of problems of the prior art, the present invention provides a kind of integrated protein pre-treatment and polypeptide high ph-values The protein group reactor of reverse phase classification and its application, can be in situ by using protein group reactor provided by the invention Realize the overall process that preenrichment, reduction, alkylation, enzymolysis, the desalination of polypeptide, elution and the high ph-values reverse phase of protein are classified, And the efficiency for improving enzymolysis and classification is, it can be achieved that the protein Large scale identification of a small amount of cell sample, improve reproducibility and Quantitative analysis accuracy.In addition, protein group reactor provided by the invention can realize automation mechanized operation.
For this purpose, the present invention uses following technical scheme:
In a first aspect, the present invention provides a kind of protein group reactor, protein pre-treatment and polypeptide can be integrated High ph-values reverse phase is classified;The protein group reactor includes liquid-transfering gun pipette tips 1, strong cation-exchanging resin filler 2 and solid phase Spe membrane 3;Solid-phase extraction membrane 3 is filled in the lower end of liquid-transfering gun pipette tips 1, and strong cation-exchanging resin filler 2 is filled in liquid-transfering gun 1 lower end of pipette tips is simultaneously located on solid-phase extraction membrane 3.
The heretofore described preenrichment of " protein example pre-treatment " including protein, reduction, alkylation, enzymolysis, The operations such as the desalination of polypeptide and elution, the protease used in each operating process, reducing agent, alkylating reagent and buffering The reagent that salting liquid etc. is all known in the art, typical but non-limiting example are:Protein can be the group of biological sample It knits, the extracting solution of protein or standard protein of cell or body fluid;Protease can be coagulated selected from alkali protease such as trypsase, pancreas Galactase or elastoser etc.;Reducing agent can be selected from dithiothreitol (DTT), trichloroethyl phosphate, beta -mercaptoethanol etc., alkane Base reagent can be iodo acetic acid or iodoacetamide etc..
Heretofore described " classification of polypeptide high ph-values reverse phase " refers to that the principle based on reversed-phase liquid chromatography realizes polypeptide Classification.The characteristics of wherein reversed-phase liquid chromatography (reverse-phase liquid chromatography, RPLC) is stationary phase Polarity than weak mobile phase, due to the hydrophobicity of RPLC stationary phase carriers, it can be according to separated object matter molecule in mobile phase It is hydrophobic different and interaction of different strengths and weaknesses occurs, so as to which different molecular be made to be separated from each other in reversed-phase column, hydrophobicity Weaker sample molecule and fixed alternate interaction are weaker, can just be flowed out when organic solvent content is relatively low in mobile phase; Conversely, the relatively stronger molecule of hydrophobicity and fixed alternate there are stronger interaction, the organic solvent content in mobile phase It could be flowed out when higher, it is thus achieved that the classification of polypeptide.
In protein group reactor of the present invention, the strong cation-exchanging resin filler is sulfonic group strong cation Exchanger resin filler.
Preferably, the solid-phase extraction membrane is C18Film.
Protein group reactor of the present invention can be used in the pre-treatment of in-situ accomplishes protein example and the high pH of polypeptide It is worth reverse phase classification, specifically includes:Preenrichment, reduction, alkylation, enzymolysis, the desalination of polypeptide, elution and the high ph-values of protein The overall process of reverse phase classification, wherein, high ph-values refer to pH value higher than 8, such as pH value is 8,9,9.2,9.5 or 10 etc..
When in use, concrete operations are as follows for protein reactor of the present invention:As shown in (B) in Fig. 1, by supporting block 4 are placed in 5 upper end of collecting pipe, and protein group reactor is placed in by supporting block 4 on collecting pipe 5, collecting pipe 5 is put into centrifugation In machine 6, protein solution or reagent can be made to flow through protein group reactor by centrifugal action, complete the pre- richness of protein The operations such as collection, enzymolysis, the elution of polypeptide and the classification of high ph-values reverse phase.In addition, protein group reactor provided by the invention can be real Existing automation mechanized operation;For example, the protein group can be used on the automatic fluid processing platform Bravo of agilent company Reactor technology automation handles multiple samples simultaneously with high throughput.
Second aspect, the present invention also provides a kind of automation reaction system of protein, the automation reaction system Including protein group reactor as described in relation to the first aspect.
Preferably, the automation reaction system further includes automatic fluid processing platform, such as can be Agilent Bravo platforms.
The third aspect, the present invention also provides protein group reactor as described in relation to the first aspect in cell or tissue sample Application in the protein identification and quantitative proteomics of product, the protein in particular for a small amount of cell or tissue sample are big Application in scale identification and quantification proteomics.
In specific application, mainly by the protein group reactor for the pre-treatment of sample in biological sample and more Peptide high ph-values reverse phase is classified, and the protein example in biological sample is digested on strong cation-exchanging resin filler, enzyme The polypeptide of generation is transferred on solid-phase extraction membrane after the completion of solution, then carries out high ph-values reverse phase classification, with realize improve enzymolysis and The technology requirement of classification efficiency.
In the present invention, in the protein that the protein group reactor described in first aspect is used for cell or tissue sample When in identification and quantification proteomics, concrete operations include the following steps:
(1) cell or tissue sample are added to preactivated good protein group reaction after lysate cracks and is acidified In device, made on protein-enriched to strong cation-exchanging resin filler by centrifugation;
(2) surface being attached on solid-phase extraction membrane is washed using the solution containing organic solvent or pure organic solvent Activating agent sequentially adds corresponding reagent and enzyme, completes the reduction, alkylation and enzymolysis of protein;
(3) polypeptide of generation is transferred to from strong cation-exchanging resin filler on solid-phase extraction membrane using salting liquid;
(4) after desalination, using the solution containing different proportion organic solvent of high ph-values in ratio from low to high successively Polypeptide is eluted, carries out high ph-values reverse phase classification.
Preferably, during step (4) described classification should be higher than that 8 using the pH value of solution.
Surfactant in step (1) described lysate is that the classification of high ph-values reverse phase and liquid chromatography-mass spectrography are compatible with, Preferably dodecyl-β-D-Maltose glycosides (n-dodecyl β-D-maltoside, DDM), cholesteryl hemisuccinate three Any one or two kinds in hydroxymethyl aminomethane salt (Cholesteryl hemisuccinate tris salt, CHS) Mixture.
Present invention employs the lysates of compatibility, i.e. surfactant in lysate is the classification of high ph-values reverse phase and liquid Phase chromatography-mass spectroscopy compatibility, as dodecyl-β-D-Maltose glycosides (n-dodecyl β-D-maltoside, DDM), courage are solid Alcohol monomester succinate trishydroxymethylaminomethane salt (Cholesteryl hemisuccinate tris salt, CHS) etc., from And be integrated into the high ph-values reverse phase classification technique of polypeptide in the protein group reactor of the present invention, improve the identification number of protein Amount.
The solution containing organic solvent is selected from the potassium citrate aqueous solution containing acetonitrile and/or methanol described in step (2), In, the volume content of acetonitrile and/or methanol in the solution is 20%, and potassium citrate is a concentration of in the solution 8mmol/L。
Preferably, step (2) the pure organic solvent is acetonitrile and/or methanol.
Preferably, step (3) described salting liquid is volatile salts solution, preferably ammonium formate and/or ammonium hydrogen carbonate.
Compared with prior art, the present invention at least has the advantages that:
(1) protein group reactor of the invention be integrated in a liquid-transfering gun pipette tips preenrichment of protein, reduction, Alkylation, enzymolysis, the desalination of polypeptide, elution and high ph-values reverse phase classification etc. operations, realize that the protein of a small amount of cell sample is big Scale is identified, improves reproducibility and quantitative analysis accuracy, and can realize the enzymolysis that protein is efficiently completed in 15min; In addition, the protein group reactor of the present invention can realize automation mechanized operation.
(2) the invention further relates to the lysates of compatibility, i.e. surfactant in lysate is the classification of high ph-values reverse phase With liquid chromatography-mass spectrography compatibility, such as dodecyl-β-D-Maltose glycosides (n-dodecyl β-D-maltoside, DDM) and Cholesteryl hemisuccinate trishydroxymethylaminomethane salt (Cholesteryl hemisuccinate tris salt, CHS), So as to which the high ph-values reverse phase classification technique of polypeptide is integrated into the protein group reactor of the present invention, the identification of protein is improved Quantity.
(3) the invention further relates to cleaning C18The operation of surfactant on film, i.e., by protein-enriched to strong cation After on exchanger resin filler, wash using the solution containing organic solvent or pure organic solvent and be attached to C18Table on film Face activating agent.
(4) protein group reactor of the invention carries out the enzymolysis of protein and point of polypeptide on different materials respectively Grade, i.e., protein is digested on strong cation-exchanging resin filler, and the polypeptide of generation is transferred to C after the completion of enzymolysis18Film On, then high ph-values reverse phase classification is carried out, be conducive to improve the efficiency of enzymolysis and classification.
Description of the drawings
Structure diagram (B) when Fig. 1 is protein group reactor (A) of the present invention and concrete operations.
In figure:1- liquid-transfering gun pipette tips, 2- strong cation-exchanging resin fillers, 3-C18Film, 4- supporting blocks, 5- collecting pipes, 6- Centrifuge.
Fig. 2 be surfactant be 1% (w/v) DDM or 1% (v/v) Triton X-100 when (A) lysate albumen Matter extraction efficiency compares;(B) comparison of polypeptide chromatogram, the peak containing DDM are marked with " I ", the peak containing Triton X-100 It is marked with " * ".
Fig. 3 is the high ph-values reverse phase classification of the present invention and the proteins and peptides quantitative comparison identified when not being classified.
Fig. 4 is the label-free analytical performance evaluation of the protein group reactor of the present invention.Wherein, (A)-(C) is to appoint The linear fit result of the meaning label-free intensity of experimental identification protein twice;(D)-(F) is arbitrary experimental identification twice The distribution of the label-free intensity rate of protein.R1, R2 and R3 represent experiment 1,2 and 3 and identify the nonstandard of protein respectively Remember quantitative intensities.
Fig. 5 is influence of the enzymolysis time to protein identification quantity.
The present invention is described in more detail below.But following examples is only the simple example of the present invention, not generation Table or limitation the scope of the present invention, protection scope of the present invention are subject to claims.
Specific embodiment
Technical solution to further illustrate the present invention below with reference to the accompanying drawings and specific embodiments.
For the present invention is better described, technical scheme of the present invention is easy to understand, of the invention is typical but non-limiting Embodiment is as follows:
First, the present invention provides a kind of lysates of compatibility.Rare cell protein group reactor (RCPR) uses Lysate be very suitable for the cracking of a small amount of cell, ingredient is 10mmol/L HEPES, pH7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 1%Triton X-100 and protease support Preparation.But the surfactant Triton X-100 in lysate are not that liquid chromatography-mass spectrography is compatible with, such as (B) in Fig. 2 It is shown, occur much influencing polypeptide inspection with the relevant strong peaks of Triton X-100 in the polypeptide chromatogram for using the lysate It surveys.Therefore, we change 1%Triton X-100 into 1%DDM.As shown in (A) in Fig. 2, the protein of the lysate containing 1%DDM Extraction efficiency is suitable with the lysate effect of original RCPR.Moreover, it can see in polypeptide chromatogram ((B) in Fig. 2), with DDM Relevant peak just comes out in final time section, does not influence polypeptide detection, therefore, the lysate of the invention containing DDM is liquid phase Chromatography-mass spectroscopy compatibility.
The protein group reactor of the present invention is integrated with the high ph-values reverse phase progressive operation of polypeptide, so as to increase polypeptide and The identification number of protein.As shown in figure 3, during 50,000 HEK 293T cell of analysis, can be identified after the classification of high ph-values reverse phase 57,008 polypeptides and 6,821 protein are 2.2 times when not being classified and 1.7 times respectively.
The protein group reactor of the present invention has higher sensitivity.As shown in table 1.6 μ g of similary processing come from HEK The protein example of 293T cells, does not do the high ph-values reverse phase classification of polypeptide, and protein group reactor of the invention can reflect Determine to 19,493 polypeptides and 3,693 protein, be the protein group reactor (Centrifugal of centrifugation respectively Proteomic Reactor) 2.8 times and 1.7 times.
As shown in table 2, protein group reactor of the invention is from 2,000,5,000,20,000,50,000 and 100,000 1,270,2,566,5,749,6,821 and 7,826 protein are identified in a HEK 293T cells respectively.And RCPR is from 5, 409 and 2,281 protein are identified in 000 and 50,000 cell respectively.In the case of same cell amount, egg of the invention The sensitivity of white matter group reactor is 6.3 times and 3.0 times of RCPR.
Table 1
Technology Identify polypeptide quantity Identify protein quantity
The protein group reactor of the present invention 19,493 3,693
The protein group reactor of centrifugation 6,888 2,145
Table 2
The protein group reactor of the present invention is applied to 100,000 people deciduous teeth pulp matrix stem cell (stem of processing Cells from human exfoliated deciduous teeth, SHED) sample.The result tested three times such as 3 institute of table Show, experiment every time can identify more than 7,000 protein, test identify 120,456 polypeptides and 9 altogether three times, 078 Protein, this is the maximum protein data collection of SHED cells so far.
Table 3
Experiment number Identify polypeptide quantity Identify protein quantity
Experiment 1 87,150 7,765
Experiment 2 78,211 7,257
Experiment 3 77,650 7,364
Amalgamation result 120,456 9,078
The label-free intensity of the protein of experimental identification three times is obtained using MaxQuant softwares, is arbitrarily tested twice Linear fit the results are shown in Figure 4, coefficient R be more than 0.98.The label-free of arbitrary experimental identification protein twice The distribution of intensity rate is as shown in figure 4, the ratio variation of 97% protein is less than 2.The result shows that protein group of the invention is anti- Sensitivity and the label-free analysis ability for answering device are suitable with in-StageTip method.
Since traditional free solution enzyme solution needs enzymolysis overnight.And the protein group reactor of the present invention has enzyme Solve time short, efficient advantage.As shown in figure 5, use described 20, the 000 HEK 293T of protein group reactor for treatment Cell can identify more than 2,900 protein when not being classified.Also, when enzymolysis time was dropped to 15 minutes by 120 minutes, The protein amounts of identification are not reduced.Therefore, protein group reactor of the invention can be efficiently complete in 15 minutes Into the enzymolysis of protein.
Embodiment 1
As shown in (A) and (B) in Fig. 1, the albumen of a kind of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase Matter group reactor, including liquid-transfering gun pipette tips 1, strong cation-exchanging resin filler 2 and C18Film 3.Wherein, liquid-transfering gun pipette tips 1 are mark 200 accurate μ L pipette tips, C18Film 3 (3M Empore, USA) is filled in 1 lower end of liquid-transfering gun pipette tips, the strong sun of length about 3mm, 1.2mg from Sub-exchange resin filler (sulfonic group strong cation-exchanging resin filler) 2 (Applied Biosystems, USA) is filled in liquid relief 1 lower end of rifle pipette tips and C18On film 3.
Supporting block 4 is placed in 5 upper end of 1.5mL collecting pipes, protein group reactor is placed in collecting pipe 5 by supporting block 4 On, collecting pipe 5 is put into centrifuge 6, protein solution can be made by centrifugal action or reagent to flow through protein group anti- Device is answered, the operations such as preenrichment, enzymolysis, the desalination of polypeptide and the classification of high ph-values reverse phase of protein is completed, is as follows:
50,000 cell sample is taken, adds in 25 μ L compatibility lysates, lysate ingredient is 10mmol/L HEPES, pH 7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 1%DDM With protease inhibitor, add in trifluoroacetic acid after the completion of cracking and sample solution is acidified to pH2.Protein group reactor divides first Do not pass through the 10mmol/L potassium citrate aqueous solutions of the methanol of 20 μ L, the 100mmol/L potassium citrates aqueous solution of 20 μ L and 20 μ L Activation.After activation, sample is added in protein reactor, by the centrifuge 6 centrifugation make protein-enriched to it is strong it is positive from On sub-exchange resin filler 2;Then, fall to be attached to C using the 8mmol/L potassium citrates aqueous cleaning containing 20% acetonitrile18 Surfactant D DM on film 3;Then, (2- carboxyethyls) the phosphonium salt hydrochlorates of 10mmol/L tri- (Tris (2- are added in Carboxyethyl) phosphine hydrochloride, TCEP) solution, reacts 15 minutes, completes protein at room temperature Reduction.Then, 20 μ L ultra-pure waters are added in and washes away TCEP, it is molten to add the 10mmol/L iodacetyl ammoniums containing 4 μ g trypsase Liquid reacts 60 minutes under room temperature and dark environment, completes alkylation and the enzymolysis of protein.Then, using 20 μ L's The polypeptide of generation is transferred to C by 200mmol/L formic acid aqueous ammonium from strong cation-exchanging resin filler 218On film 3;Then, add The 5mmol/L formic acid aqueous ammonium for entering 20 μ L carries out desalination.Finally, using pH value be 10 respectively containing 3%, 6%, 9%, 15%th, the 5mmol/L ammonium formate solutions of 80% acetonitrile successively elute polypeptide, that is, carry out high ph-values reverse phase classification.Elution The polypeptide to get off is redissolved after freeze dryer freeze-drying in 0.1% aqueous formic acid, you can is analyzed with liquid chromatography-mass spectrography.
It can be with using 20,000 HEK 293T cell of protein group reactor for treatment described in the present embodiment, when not being classified It identifies more than 2,900 protein, also, when enzymolysis time was dropped to 15 minutes by 120 minutes, the protein amounts of identification are simultaneously Do not reduce.Therefore, the protein group reactor of the present embodiment can efficiently complete the enzymolysis of protein in 15 minutes.
Embodiment 2
A kind of integrated protein pre-treatment and the protein group reactor of polypeptide high ph-values reverse phase classification, including liquid-transfering gun rifle First 1, strong cation-exchanging resin filler 2 and C18Film 3.Wherein, 200 μ L pipette tips of the liquid-transfering gun pipette tips 1 for standard, C183 (3M of film Empore, USA) 1 lower end of liquid-transfering gun pipette tips is filled in, length about 3mm, (sulfonic group is strong for 1.2mg strong cation-exchanging resins filler Cation exchange resin filler) 2 (Applied Biosystems, USA) are filled in 1 lower end of liquid-transfering gun pipette tips and C18On film 3.
Supporting block 4 is placed in 5 upper end of 1.5mL collecting pipes, protein group reactor is placed in collecting pipe 5 by supporting block 4 On, collecting pipe 5 is put into centrifuge 6, protein solution can be made by centrifugal action or reagent to flow through protein group anti- Device is answered, the operations such as preenrichment, enzymolysis, the desalination of polypeptide and the classification of high ph-values reverse phase of protein is completed, is as follows:
50,000 cell sample is taken, adds in 25 μ L compatibility lysates, lysate ingredient is 10mmol/L HEPES, pH 7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 1% courage consolidates Alcohol monomester succinate trishydroxymethylaminomethane salt (Cholesteryl hemisuccinate tris salt, CHS) and albumen Enzyme inhibitor adds in trifluoroacetic acid after the completion of cracking and sample solution is acidified to pH2.Protein group reactor passes through respectively first The 10mmol/L potassium citrate activated in water solution of the methanol of 20 μ L, the 100mmol/L potassium citrates aqueous solution of 20 μ L and 20 μ L.It is living After change, sample is added in protein reactor, makes protein-enriched to strong cation exchange tree by being centrifuged in centrifuge 6 On fat filler 2;Then, fall to be attached to C using the 8mmol/L potassium citrates aqueous cleaning containing 20% acetonitrile18Table on film 3 Face activating agent CHS;Then, 10mmol/L tri- (2- carboxyethyls) phosphonium salt hydrochlorate (Tris (2-carboxyethyl) is added in Phosphine hydrochloride, TCEP) solution, reacts 15 minutes, completes the reduction of protein at room temperature.Then, add Enter 20 μ L ultra-pure waters and wash away TCEP, the 10mmol/L iodacetyl ammonium salt solutions containing 4 μ g trypsase are added, in room temperature and dark In the environment of react 60 minutes, complete alkylation and the enzymolysis of protein.Then, using the 200mmol/L ammonium formate water of 20 μ L The polypeptide of generation is transferred to C by solution from strong cation-exchanging resin filler 218On film 3;Then, the 5mmol/L first of 20 μ L is added in Sour aqueous ammonium carries out desalination.Finally, using pH value be 10 respectively containing 3%, 6%, 9%, 15%, 80% acetonitrile 5mmol/L ammonium formate solutions successively elute polypeptide, that is, carry out high ph-values reverse phase classification.The polypeptide eluted is being lyophilized It is redissolved after machine freeze-drying in 0.1% aqueous formic acid, you can analyzed with liquid chromatography-mass spectrography.
It can be with using 20,000 HEK 293T cell of protein group reactor for treatment described in the present embodiment, when not being classified It identifies more than 2,900 protein, also, when enzymolysis time was dropped to 16 minutes by 120 minutes, the protein amounts of identification are simultaneously Do not reduce.Therefore, the protein group reactor of the present embodiment can efficiently complete the enzymolysis of protein in 16 minutes.
Embodiment 3
A kind of integrated protein pre-treatment and the protein group reactor of polypeptide high ph-values reverse phase classification, including liquid-transfering gun rifle First 1, strong cation-exchanging resin filler 2 and C18Film 3.Wherein, 200 μ L pipette tips of the liquid-transfering gun pipette tips 1 for standard, C183 (3M of film Empore, USA) 1 lower end of liquid-transfering gun pipette tips is filled in, length about 3mm, (sulfonic group is strong for 1.2mg strong cation-exchanging resins filler Cation exchange resin filler) 2 (Applied Biosystems, USA) are filled in 1 lower end of liquid-transfering gun pipette tips and C18On film 3.
Supporting block 4 is placed in 5 upper end of 1.5mL collecting pipes, protein group reactor is placed in collecting pipe 5 by supporting block 4 On, collecting pipe 5 is put into centrifuge 6, protein solution can be made by centrifugal action or reagent to flow through protein group anti- Device is answered, the operations such as preenrichment, enzymolysis, the desalination of polypeptide and the classification of high ph-values reverse phase of protein is completed, is as follows:
50,000 cell sample is taken, adds in 25 μ L compatibility lysates, lysate ingredient is 10mmol/L HEPES, pH 7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 0.5% DDM, 0.5%CHS and protease inhibitor add in trifluoroacetic acid after the completion of cracking and sample solution are acidified to pH2.Protein group Reactor passes through the 10mmol/L lemons of the methanol of 20 μ L, the 100mmol/L potassium citrates aqueous solution of 20 μ L and 20 μ L respectively first Lemon acid aqueous solutions of potassium activates.After activation, sample is added in protein reactor, makes protein by being centrifuged in centrifuge 6 It is enriched on strong cation-exchanging resin filler 2;Then, it is clear using the 8mmol/L potassium citrate aqueous solutions containing 20% acetonitrile It washes off and is attached to C18Surfactant D DM and CHS on film 3;Then, 10mmol/L tri- (2- carboxyethyls) phosphonium salt hydrochlorate is added in (Tris (2-carboxyethyl) phosphine hydrochloride, TCEP) solution reacts 15 minutes at room temperature, complete Into the reduction of protein.Then, 20 μ L ultra-pure waters are added in and washes away TCEP, add the 10mmol/L iodine containing 4 μ g trypsase Acetyl ammonium salt solution reacts 60 minutes under room temperature and dark environment, completes alkylation and the enzymolysis of protein.Then, it uses The polypeptide of generation is transferred to C by the 200mmol/L formic acid aqueous ammonium of 20 μ L from strong cation-exchanging resin filler 218On film 3; Then, the 5mmol/L formic acid aqueous ammonium for adding in 20 μ L carries out desalination.Finally, using pH value be 10 respectively containing 3%, 6%th, the 5mmol/L ammonium formate solutions of 9%, 15%, 80% acetonitrile successively elute polypeptide, that is, carry out high ph-values reverse phase point Grade.The polypeptide eluted is redissolved after freeze dryer freeze-drying in 0.1% aqueous formic acid, you can is carried out with liquid chromatography-mass spectrography Analysis.
It can be with using 20,000 HEK 293T cell of protein group reactor for treatment described in the present embodiment, when not being classified It identifies more than 2,900 protein, also, when enzymolysis time was dropped to 18 minutes by 120 minutes, the protein amounts of identification are simultaneously Do not reduce.Therefore, the protein group reactor of the present embodiment can efficiently complete the enzymolysis of protein in 18 minutes.
Embodiment 4
A kind of integrated protein pre-treatment and the protein group reactor of polypeptide high ph-values reverse phase classification, including liquid-transfering gun rifle First 1, strong cation-exchanging resin filler 2 and C18Film 3.Wherein, 200 μ L pipette tips of the liquid-transfering gun pipette tips 1 for standard, C183 (3M of film Empore, USA) 1 lower end of liquid-transfering gun pipette tips is filled in, length about 3mm, (sulfonic group is strong for 1.2mg strong cation-exchanging resins filler Cation exchange resin filler) 2 (Applied Biosystems, USA) are filled in 1 lower end of liquid-transfering gun pipette tips and C18On film 3.
Supporting block 4 is placed in 5 upper end of 1.5mL collecting pipes, protein group reactor is placed in collecting pipe 5 by supporting block 4 On, collecting pipe 5 is put into centrifuge 6, protein solution can be made by centrifugal action or reagent to flow through protein group anti- Device is answered, the operations such as preenrichment, enzymolysis, the desalination of polypeptide and the classification of high ph-values reverse phase of protein is completed, is as follows:
50,000 cell sample is taken, adds in 25 μ L compatibility lysates, lysate ingredient is 10mmol/L HEPES, pH 7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 0.5% DDM, 0.5%CHS and protease inhibitor add in trifluoroacetic acid after the completion of cracking and sample solution are acidified to pH2.Protein group Reactor passes through the 10mmol/L lemons of the methanol of 20 μ L, the 100mmol/L potassium citrates aqueous solution of 20 μ L and 20 μ L respectively first Lemon acid aqueous solutions of potassium activates.After activation, sample is added in protein reactor, makes protein by being centrifuged in centrifuge 6 It is enriched on strong cation-exchanging resin filler 2;Then, using the 8mmol/L citric acids containing 10% acetonitrile and 10% methanol Aqueous solutions of potassium, which washes, is attached to C18Surfactant D DM and CHS on film 3;Then, 10mmol/L tri- (2- carboxyethyls) is added in Phosphonium salt hydrochlorate (Tris (2-carboxyethyl) phosphine hydrochloride, TCEP) solution, reacts 15 at room temperature Minute, complete the reduction of protein.Then, 20 μ L ultra-pure waters are added in and washes away TCEP, added containing 4 μ g trypsase 10mmol/L iodacetyl ammonium salt solutions react 60 minutes under room temperature and dark environment, complete alkylation and the enzymolysis of protein. Then, the polypeptide of generation is transferred to from strong cation-exchanging resin filler 2 using the 200mmol/L formic acid aqueous ammonium of 20 μ L C18On film 3;Then, the 5mmol/L formic acid aqueous ammonium for adding in 20 μ L carries out desalination.Finally, the use of pH value is 10 respectively to contain The 5mmol/L ammonium formate solutions for having 3%, 6%, 9%, 15%, 80% acetonitrile successively elute polypeptide, that is, carry out high ph-values Reverse phase is classified.The polypeptide eluted is redissolved after freeze dryer freeze-drying in 0.1% aqueous formic acid, you can with liquid chromatogram-matter Spectrum is analyzed.
It can be with using 20,000 HEK 293T cell of protein group reactor for treatment described in the present embodiment, when not being classified It identifies more than 2,900 protein, also, when enzymolysis time was dropped to 20 minutes by 120 minutes, the protein amounts of identification are simultaneously Do not reduce.Therefore, the protein group reactor of the present embodiment can efficiently complete the enzymolysis of protein in 20 minutes.
Embodiment 5
A kind of integrated protein pre-treatment and the protein group reactor of polypeptide high ph-values reverse phase classification, including liquid-transfering gun rifle First 1, strong cation-exchanging resin filler 2 and C18Film 3.Wherein, 200 μ L pipette tips of the liquid-transfering gun pipette tips 1 for standard, C183 (3M of film Empore, USA) 1 lower end of liquid-transfering gun pipette tips is filled in, length about 3mm, (sulfonic group is strong for 1.2mg strong cation-exchanging resins filler Cation exchange resin filler) 2 (Applied Biosystems, USA) are filled in 1 lower end of liquid-transfering gun pipette tips and C18On film 3.
Supporting block 4 is placed in 5 upper end of 1.5mL collecting pipes, protein group reactor is placed in collecting pipe 5 by supporting block 4 On, collecting pipe 5 is put into centrifuge 6, protein solution can be made by centrifugal action or reagent to flow through protein group anti- Device is answered, the operations such as preenrichment, enzymolysis, the desalination of polypeptide and the classification of high ph-values reverse phase of protein is completed, is as follows:
50,000 cell sample is taken, adds in 25 μ L compatibility lysates, lysate ingredient is 10mmol/L HEPES, pH 7.4,150mmol/L NaCl, 2mmol/L CaCl2, 2mmol/L MgCl2, 600mmol/L guanidine HCl, 1%DDM With protease inhibitor, add in trifluoroacetic acid after the completion of cracking and sample solution is acidified to pH2.Protein group reactor divides first Do not pass through the 10mmol/L potassium citrate aqueous solutions of the methanol of 20 μ L, the 100mmol/L potassium citrates aqueous solution of 20 μ L and 20 μ L Activation.After activation, sample is added in protein reactor, by the centrifuge 6 centrifugation make protein-enriched to it is strong it is positive from On sub-exchange resin filler 2;Then, fall to be attached to C using the 8mmol/L potassium citrates aqueous cleaning containing 20% acetonitrile18 Surfactant D DM on film 3;Then, (2- carboxyethyls) the phosphonium salt hydrochlorates of 10mmol/L tri- (Tris (2- are added in Carboxyethyl) phosphine hydrochloride, TCEP) solution, reacts 15 minutes, completes protein at room temperature Reduction.Then, 20 μ L ultra-pure waters are added in and washes away TCEP, it is molten to add the 10mmol/L iodacetyl ammoniums containing 4 μ g trypsase Liquid reacts 60 minutes under room temperature and dark environment, completes alkylation and the enzymolysis of protein.Then, using 20 μ L's The polypeptide of generation is transferred to C by 200mmol/L formic acid aqueous ammonium from strong cation-exchanging resin filler 218On film 3;Then, add The 5mmol/L formic acid aqueous ammonium for entering 20 μ L carries out desalination.Finally, using pH value be 10 respectively containing 3%, 6%, 9%, 15%th, the 5mmol/L ammonium formates of 80% acetonitrile and ammonium bicarbonate soln successively elute polypeptide, that is, carry out high ph-values reverse phase Classification.The polypeptide eluted freeze dryer freeze-drying after redissolve in 0.1% aqueous formic acid, you can with liquid chromatography-mass spectrography into Row analysis.
It can be with using 20,000 HEK 293T cell of protein group reactor for treatment described in the present embodiment, when not being classified It identifies more than 2,900 protein, also, when enzymolysis time was dropped to 17 minutes by 120 minutes, the protein amounts of identification are simultaneously Do not reduce.Therefore, the protein group reactor of the present embodiment can efficiently complete the enzymolysis of protein in 17 minutes.
Applicant states that the present invention illustrates the detailed construction feature of the present invention by above-described embodiment, but the present invention is simultaneously Above-mentioned detailed construction feature is not limited to, that is, does not mean that the present invention has to rely on above-mentioned detailed construction feature and could implement.Institute Belong to those skilled in the art it will be clearly understood that any improvement in the present invention, to the equivalence replacement of component selected by the present invention And the increase of accessory, selection of concrete mode etc., it all falls within protection scope of the present invention and the open scope.
The preferred embodiment of the present invention has been described above in detail, still, during present invention is not limited to the embodiments described above Detail, within the scope of the technical concept of the present invention, a variety of simple variants can be carried out to technical scheme of the present invention, this A little simple variants all belong to the scope of protection of the present invention.
It is further to note that specific technical features described in the above specific embodiments, in not lance In the case of shield, can be combined by any suitable means, in order to avoid unnecessary repetition, the present invention to it is various can The combination of energy no longer separately illustrates.
In addition, various embodiments of the present invention can be combined randomly, as long as it is without prejudice to originally The thought of invention, it should also be regarded as the disclosure of the present invention.

Claims (8)

1. a kind of method of biological sample pre-treatment and polypeptide high ph-values reverse phase classification based on protein group reactor, feature It is, the protein group reactor includes liquid-transfering gun pipette tips(1), strong cation-exchanging resin filler(2)And solid-phase extraction membrane (3);Solid-phase extraction membrane(3)It is filled in liquid-transfering gun pipette tips(1)Lower end, strong cation-exchanging resin filler(2)It is filled in liquid relief Rifle pipette tips(1)Lower end is simultaneously located at solid-phase extraction membrane(3)On;
The protein group reactor for biological sample pre-treatment and polypeptide high ph-values reverse phase classification specific method be:It will Protein example enrichment in biological sample is restored on strong cation-exchanging resin filler, is alkylated and digested, enzymolysis The polypeptide of generation is transferred on solid-phase extraction membrane after the completion, then carries out high ph-values reverse phase classification, the high ph-values refer to pH value Higher than 9;
The protein group reactor is used for the specific behaviour of the pre-treatment of sample and the classification of polypeptide high ph-values reverse phase in biological sample It is as step:(1)Cell or tissue sample are added to preactivated good protein group reaction after lysate cracks and is acidified In device, made on protein-enriched to strong cation-exchanging resin filler by centrifugation;
(2)The surface-active being attached on solid-phase extraction membrane is washed using the solution containing organic solvent or pure organic solvent Agent sequentially adds corresponding reagent and enzyme, completes the reduction, alkylation and enzymolysis of protein;
(3)The polypeptide of generation is transferred to from strong cation-exchanging resin filler on solid-phase extraction membrane using salting liquid;
(4)The use of the solution containing different proportion organic solvent of high ph-values in ratio from low to high will be more successively after desalination Peptide elutes, and carries out high ph-values reverse phase classification;
Wherein, step(1)Surfactant in the lysate is the classification of high ph-values reverse phase and liquid chromatography-mass spectrography compatibility , the surfactant is dodecyl-β-D-Maltose glycosides, cholesteryl hemisuccinate trishydroxymethylaminomethane salt In any one or two kinds mixture.
2. according to the method described in claim 1, it is characterized in that, the strong cation-exchanging resin filler is positive by force for sulfonic group Ion exchange resin filler.
3. according to the method described in claim 1, it is characterized in that, the solid-phase extraction membrane is C18Film.
4. according to the method described in claim 1, it is characterized in that, step(2)The solution containing organic solvent, which is selected from, to be contained The potassium citrate aqueous solution of acetonitrile and/or methanol, wherein, the volume content of acetonitrile and/or methanol in the solution is 20%, A concentration of 8mmol/L of the potassium citrate in the solution.
5. according to the method described in claim 1, it is characterized in that, step(2)The pure organic solvent is acetonitrile and/or first Alcohol.
6. according to the method described in claim 1, it is characterized in that, step(3)The salting liquid is volatile salts solution.
7. according to the method described in claim 6, it is characterized in that, the salting liquid is ammonium formate and/or ammonium hydrogen carbonate.
8. protein identification and quantitative proteomics are used for according to claim 1-7 any one of them method.
CN201610199973.1A 2016-03-31 2016-03-31 The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase Active CN105866317B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201610199973.1A CN105866317B (en) 2016-03-31 2016-03-31 The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase
US16/089,503 US11959891B2 (en) 2016-03-31 2017-01-05 Proteomics reactor, protein chromatographic separation platform and use thereof
PCT/CN2017/070336 WO2017166897A1 (en) 2016-03-31 2017-01-05 Proteomic reactor, protein chromatographic separation platform and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610199973.1A CN105866317B (en) 2016-03-31 2016-03-31 The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase

Publications (2)

Publication Number Publication Date
CN105866317A CN105866317A (en) 2016-08-17
CN105866317B true CN105866317B (en) 2018-06-29

Family

ID=56627743

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610199973.1A Active CN105866317B (en) 2016-03-31 2016-03-31 The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase

Country Status (1)

Country Link
CN (1) CN105866317B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106770814B (en) * 2016-11-18 2019-04-26 南方科技大学 A kind of protein chromatography separation platform and its application
WO2017166897A1 (en) * 2016-03-31 2017-10-05 南方科技大学 Proteomic reactor, protein chromatographic separation platform and use thereof
CN108072555A (en) * 2016-11-16 2018-05-25 中国科学院大连化学物理研究所 A kind of analysis and processing method of protein methylation and its application
CN108226317B (en) * 2016-12-21 2020-10-20 复旦大学 Method for performing whole proteomics analysis based on cell level
CN107402269B (en) * 2017-07-31 2021-02-09 南方科技大学 Integrated proteomics sample pretreatment platform based on SCX/SAX mixed filler and application thereof
CN108387666A (en) * 2018-03-01 2018-08-10 南方科技大学 A kind of proteomics Mass Spectrometry detection method for urine specimen
CN108645934B (en) * 2018-05-31 2021-03-30 中山大学孙逸仙纪念医院 Mini-protein reactor applied to proteome sample preparation and application thereof
CN109142561A (en) * 2018-07-17 2019-01-04 上海师范大学 The method and its application of simultaneous quantitative protein abundance and cysteine oxidation level
CN109061016A (en) * 2018-07-25 2018-12-21 大连工业大学 A kind of preparation method and application of the solid-phase extraction column of enriched biological amine
CN109541223A (en) * 2018-11-08 2019-03-29 新乡医学院 The identification method of sample to be tested palmitoylation total protein
CN110922448B (en) * 2019-12-11 2021-02-09 谱度众合(武汉)生命科技有限公司 Phosphorylated peptide enrichment device and method
CN114577955A (en) * 2020-11-30 2022-06-03 中国科学院大连化学物理研究所 High-throughput automatic single-cell proteome sample processing method
CN114509521B (en) * 2022-01-19 2023-12-19 南方科技大学 Pretreatment device and method for glycoprotein proteomics sample
CN114749221A (en) * 2022-03-25 2022-07-15 南方科技大学 Proteomics sample pretreatment device and preparation method and application thereof
CN117169489A (en) * 2023-07-18 2023-12-05 西湖实验室(生命科学和生物医学浙江省实验室) Method for processing biological samples to identify proteins therein
CN117630249A (en) * 2024-01-26 2024-03-01 华南生物医药研究院 Extremely simple proteomics sample pretreatment method based on sample loading bottle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103102388A (en) * 2011-11-11 2013-05-15 中国科学院大连化学物理研究所 Method for sequentially enriching multi-phosphopeptide and mono-phosphopeptide
CN103665098B (en) * 2012-09-20 2015-08-05 中国科学院大连化学物理研究所 Diphasic column membrane protein microreactor and application thereof
DK2934749T3 (en) * 2012-12-19 2023-02-27 Max Planck Gesellschaft REACTION CONTAINER FOR SAMPLE PREPARATION
CN104076114B (en) * 2013-03-29 2016-01-27 中国科学院大连化学物理研究所 A kind of binary channels SPE post and the application at quantitative proteomics thereof
CN104236984B (en) * 2013-06-14 2017-11-21 中国科学院大连化学物理研究所 A kind of device of biological sample purification and its application

Also Published As

Publication number Publication date
CN105866317A (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN105866317B (en) The protein group reactor and its application of integrated protein pre-treatment and the classification of polypeptide high ph-values reverse phase
AU2007340558B2 (en) Method for quantification of peptide and protein
CN106770814B (en) A kind of protein chromatography separation platform and its application
Essader et al. A comparison of immobilized pH gradient isoelectric focusing and strong‐cation‐exchange chromatography as a first dimension in shotgun proteomics
Kašička Recent developments in CE and CEC of peptides
Kellner et al. Microcharacterization of proteins
CN107402269A (en) Integrated proteomics sample pre-treatments platform and its application based on SCX/SAX mixed fillers
Hellman Sample preparation by SDS/PAGE and in-gel digestion
WO2009070233A1 (en) Internal standards and methods for use in quantitatively measuring analytes in a sample
CA2444524A1 (en) Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
WO2023134169A1 (en) Pretreatment method, storage method, automatic treatment system, and detection method for urine sample
CN110530999A (en) A kind of distinguishing method between true and false of caribou horn
Ptolemy et al. New advances in on-line sample preconcentration by capillary electrophoresis using dynamic pH junction
CN113777178A (en) Proteomics background library based on mixed spectrogram library, and construction method and application thereof
US11959891B2 (en) Proteomics reactor, protein chromatographic separation platform and use thereof
CN108548876B (en) Improved identification and quantification method of phosphorylated peptide in biological sample
CN103884807B (en) A kind of 18o is in the Protein quantitative analysis platform of wire tag and method of operating thereof
Williams et al. Internal protein sequencing of SDS-PAGE-separated proteins: optimization of an in gel digest protocol
CN105445409A (en) Method for measuring glycosylated hemoglobin by isotope dilution mass spectrometry
US20020155614A1 (en) Peptide esterification
CN102768282B (en) Preparation and detection methods of kit for detecting chub vitellogenin (VTG)
Gao et al. LC-SRM-Based targeted quantification of urinary protein biomarkers
Ranish et al. Using stable isotope tagging and mass spectrometry to characterize protein complexes and to detect changes in their composition
CN107167542B (en) A centrifugal device for phosphopeptide enrichment and separation
Michna et al. Quantitative Proteome and Phosphoproteome Profiling in Magnaporthe oryzae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20221108

Address after: 518051 309C2, Building 19, Majialong, No. 15, Hongbu Road, Majialong Community, Nantou Street, Nanshan District, Shenzhen, Guangdong

Patentee after: Shenzhen Shenweichao Biotechnology Co.,Ltd.

Address before: 421, No.2 section, South University of science and technology, 1088 Xili Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong 518000

Patentee before: SOUTH University OF SCIENCE AND TECHNOLOGY OF CHINA

TR01 Transfer of patent right
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20160817

Assignee: Shenzhen Bepuo Biotechnology Co.,Ltd.

Assignor: Shenzhen Shenweichao Biotechnology Co.,Ltd.

Contract record no.: X2023980041118

Denomination of invention: A Proteome Reactor Integrating Protein Pretreatment and High pH Reverse Grading of Peptides and Its Application

Granted publication date: 20180629

License type: Exclusive License

Record date: 20230904

EE01 Entry into force of recordation of patent licensing contract